What the Clinical Trials Show
Every major clinical trial of GLP-1 weight loss medications — including SURMOUNT-1 (Mounjaro), STEP 1 (Wegovy), and SCALE (Saxenda) — was conducted alongside lifestyle interventions. Participants received dietary counselling, were placed on reduced-calorie diets (typically a 500 kcal/day deficit), and were encouraged to increase physical activity to at least 150 minutes per week.
This means the impressive weight loss results (22.5% for Mounjaro, 14.9% for Wegovy) were achieved with medication plus lifestyle changes — not medication alone. NICE guidance for all three medications explicitly states that they should be used alongside a reduced-calorie diet and increased physical activity.
Why Medication Alone Is Not Enough
GLP-1 medications reduce appetite and food noise, making it easier to eat less. But they do not automatically ensure you eat the right foods or maintain muscle mass. Without dietary guidance, there is a risk of nutritional deficiencies — particularly protein, which is important for preserving lean muscle during rapid weight loss.
Exercise — particularly resistance training — helps maintain muscle mass, supports bone health, and improves cardiovascular fitness. These benefits are separate from weight loss itself and are not provided by medication alone.
Practical Dietary Tips While on GLP-1 Medication
Clinical guidance and patient experience suggest the following dietary approaches while taking weight loss medication:
- Prioritise protein — aim for 1.2–1.6g per kg of body weight daily to preserve muscle mass
- Eat smaller, more frequent meals — your reduced appetite means large meals may cause nausea
- Stay well hydrated — dehydration is a common issue, particularly if experiencing gastrointestinal side effects
- Focus on nutrient-dense foods — with a reduced appetite, every meal needs to count nutritionally
- Limit ultra-processed foods, sugary drinks, and alcohol
- Consider a multivitamin if your overall food intake has decreased significantly
Exercise Recommendations
NHS and NICE guidance recommends at least 150 minutes of moderate-intensity physical activity per week, or 75 minutes of vigorous activity. For patients on weight loss medication, the following is particularly important:
- Resistance training (2–3 sessions per week) to preserve muscle mass during weight loss
- Walking — a simple, accessible baseline activity that can be built upon
- Gradual progression — start with what is manageable and increase over time
- Listen to your body — fatigue and reduced calorie intake may require adjusting exercise intensity initially
Many patients find that as their weight decreases, exercise becomes more enjoyable and accessible. The medication can create a positive cycle where weight loss enables greater physical activity, which in turn supports further weight loss.
What Happens When You Stop the Medication?
NICE guidance notes that weight regain commonly occurs after stopping GLP-1 medication. The STEP 1 extension trial showed that participants who stopped semaglutide regained approximately two-thirds of their weight loss within a year. This underscores why building sustainable dietary and exercise habits during treatment is crucial.
The lifestyle changes you make while on medication are your best insurance against weight regain if treatment stops. Think of the medication as a tool that makes lifestyle change easier — not a replacement for it.